Company Performance Metrics
Ian Cameron: CEOPast Role: YFM Equity Partners, Investment Director
MicroPharm is a fully integrated developer and manufacturer of polyclonal therapeutics, targeting infectious disease and acute toxic events.
MicroPharm's core expertise lies in the raising of antisera containing high levels of specific antibodies directed against toxic molecules or viral targets and the subsequent purification and
modification of such antibodies to produce a range of immunotherapeutic products for clinical use. All are designed to treat acute, life-threatening emergencies, have been developed at the request of the medical profession and are required urgently either because no alternative exists or because any alternative is ineffective and/or unsafe.
MicroPharm also provides a contract development, manufacturing and filling service to third parties.
